Opportunities And Challenges In Cell And Gene Therapy Development

One of the most revolutionary trends driving the biopharmaceutical sector is cell and gene therapy. At its most basic definition, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient’s cells as a drug to treat disease. According to documentation published in The Journal of Gene Medicine, as of November 2017 nearly 2,600 gene therapy clinical trials have been undertaken in 38 countries around the world.

In this Q&A Dr. Ger Brophy, Executive Vice President, Biopharma Production at Avantor, gives his perspective on this exciting segment of the bioprocessing industry. He is looking forward to  working with innovative leaders, scientists and researchers in the industry who are seeking to explore and expand the potential for gene therapy.